Dose Reference Table

Pre-calculated for a 10mg vial + 2ml BAC water = 5,000 mcg/ml concentration. Using a 100-unit (1ml) insulin syringe.

Dose Inject Volume (ml) Syringe Units
1000mcg (1mg) 0.200 ml 20 units
2500mcg (2.5mg) 0.500 ml 50 units
5000mcg (5mg) 1.000 ml 100 units
7500mcg (7.5mg) 1.500 ml 150 units
10000mcg (10mg) 2.000 ml 200 units

About MOTS-C

MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA type-c) is a recently discovered mitochondria-derived peptide (MDP) encoded in the mitochondrial genome. It was first characterized in 2015 by researchers at the University of Southern California. MOTS-C represents a new class of peptide signals that coordinate nuclear gene expression from within the mitochondria.

Research on MOTS-C has explored its role in metabolic regulation, insulin sensitivity, exercise performance, and aging. It appears to work by translocating from mitochondria to the cell nucleus, where it regulates genes involved in metabolism, antioxidant defense, and stress response. Studies in animal models have shown improvements in insulin sensitivity, reductions in diet-induced obesity, and enhanced endurance exercise performance.

MOTS-C is typically supplied in 10mg vials. Using 2ml of bacteriostatic water yields 5,000 mcg/ml. Research doses have ranged from 1mg to 10mg per injection. Given the novelty of this peptide, optimal dosing protocols are still being established in the research literature.

Frequently Asked Questions

Research protocols have used doses ranging from 1–10mg per injection. Common starting doses are 5mg. For a 10mg vial + 2ml BAC water (5000 mcg/ml), 5mg = 1ml = 100 units.
MOTS-C is a mitochondria-derived peptide studied for its effects on metabolic health, insulin sensitivity, exercise performance, and longevity. It appears to regulate gene expression related to metabolism and stress response.
Add 2ml of bacteriostatic water to a 10mg MOTS-C vial for a 5000 mcg/ml concentration. Inject BAC water slowly along the glass wall. Gently swirl until dissolved. Store at 2–8°C.
Research protocols vary, but MOTS-C is commonly injected 3–5 times per week. Some researchers inject before exercise to study performance effects.
Both are mitochondria-focused peptides, but with different mechanisms. MOTS-C is a mitochondria-derived signaling peptide that regulates metabolism and gene expression. SS-31 (Elamipretide) targets cardiolipin in the inner mitochondrial membrane to improve electron transport chain efficiency.